GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,066 Cr | ₹-1,049 Cr | ₹-1,805 Cr | ₹-1,655 Cr | ₹-1,506 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1,066 Cr |
| Mar2024 | ₹-1,049 Cr |
| Mar2023 | ₹-1,805 Cr |
| Mar2022 | ₹-1,655 Cr |
| Mar2021 | ₹-1,506 Cr |
How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,066 Cr | Negative | |
| Mar2024 | ₹-1,049 Cr | Negative | |
| Mar2023 | ₹-1,805 Cr | Negative | |
| Mar2022 | ₹-1,655 Cr | Negative | |
| Mar2021 | ₹-1,506 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹62,881.2 Cr | -0.3% | 7.3% | 61.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.3% |
7.3% |
61.8% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses